Tech Company Financing Transactions

Synthego Funding Round

On 3/1/2022, Synthego raised $200 million in Series E financing from Perceptive Advisors, Chimera Partners and Declaration Partners.

Transaction Overview

Company Name
Announced On
3/1/2022
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Series E
Proceeds Purpose
Synthego will use the proceeds from the Series E financing to accelerate the creation of a cell and gene therapy discovery and development ecosystem to help researchers scale and simplify the translation of new discoveries into novel therapeutics for serious diseases.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3696 Haven Ave.
Redwood City, CA 94063
USA
Email Address
Overview
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.
Profile
Synthego LinkedIn Company Profile
Social Media
Synthego Company Twitter Account
Company News
Synthego News
Facebook
Synthego on Facebook
YouTube
Synthego on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Dabrowski
  Paul Dabrowski LinkedIn Profile  Paul Dabrowski Twitter Account  Paul Dabrowski News  Paul Dabrowski on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/1/2022: Mizar venture capital transaction
Next: 3/1/2022: Thetanuts Finance venture capital transaction

 

Share this article

 


News on VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary